These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 4293637)

  • 1. [The behavior of serum-cholesterins in patients with multiple sclerosis].
    Lienhardt M
    Schweiz Arch Neurol Neurochir Psychiatr; 1966; 98(2):258-70. PubMed ID: 4293637
    [No Abstract]   [Full Text] [Related]  

  • 2. Optic neuritis and its relationship to disseminated sclerosis.
    Landy PJ; Ohlrich GD
    Proc Aust Assoc Neurol; 1970; 7():67-70. PubMed ID: 4328431
    [No Abstract]   [Full Text] [Related]  

  • 3. [The behavior of serum immunoglobulins in multiple sclerosis during anti-inflammatory therapy].
    Paltrinieri E; Giovannucci M
    Acta Neurol (Napoli); 1969; 24(4):613-25. PubMed ID: 4101181
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effect of clinical exacerbations and ACTH therapy on the level of lipids in blood serum of patients with sclerosis].
    Szajbel W; Cendrowski W; Waszkiewicz E; Niedzielska K
    Neurol Neurochir Pol; 1968; 2(6):691-7. PubMed ID: 4303589
    [No Abstract]   [Full Text] [Related]  

  • 5. [Multiple sclerosis].
    Palo J
    Duodecim; 1973 Aug; 89(22):1479-96. PubMed ID: 4358206
    [No Abstract]   [Full Text] [Related]  

  • 6. Multiple sclerosis: etiologic and diagnostic significance of measles virus antibodies in the cerebrospinal fluid and serum.
    Cendrowski W; Niedzielska K
    Schweiz Arch Neurol Neurochir Psychiatr; 1974; 114(2):215-28. PubMed ID: 4421491
    [No Abstract]   [Full Text] [Related]  

  • 7. Plasma zinc levels in multiple sclerosis.
    Wong EK; Enomoto H; Leopold IH; Fleischer EB; Schoon DV; Fender D; Tucker HG; Adamson B; Kladde L; Kazan D; Nudleman K
    Metab Pediatr Ophthalmol; 1980; 4(1):3-8. PubMed ID: 7442341
    [No Abstract]   [Full Text] [Related]  

  • 8. Changes in serum immunoglobulin concentrations in patients with multiple sclerosis during the treatment with ACTH.
    Maciejek Z; Rebeś Z; Kubasiewicz B
    Arch Immunol Ther Exp (Warsz); 1981; 29(2):141-4. PubMed ID: 6272663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical phenomena in early and late-onset multiple sclerosis].
    Marforio S
    Minerva Med; 1977 Feb; 68(6):405-12. PubMed ID: 190562
    [No Abstract]   [Full Text] [Related]  

  • 10. [Trials of Synacthen in multiple sclerosis].
    Badino R
    Riv Neurol; 1970; 40(3):139-64. PubMed ID: 4321924
    [No Abstract]   [Full Text] [Related]  

  • 11. [Initial results of the determination of HDL-cholesterol in patients with cerebrovascular strokes and multiple sclerosis (the significance of the ratio between HDL-cholesterol and total cholesterol)].
    Opavský J; Bartek J
    Acta Univ Palacki Olomuc Fac Med; 1982; 102():299-310. PubMed ID: 6242584
    [No Abstract]   [Full Text] [Related]  

  • 12. [Critic study of multiple sclerosis treatment by chlorambucil and intraspinal corticotherapy. Apropos of 100 cases followed up from 2 to 9 years].
    Sigwald J; Mazalton A; Raymondeaud C; Piot C; Jacquillat C
    Rev Neurol (Paris); 1973 Jan; 128(1):72-7. PubMed ID: 4367744
    [No Abstract]   [Full Text] [Related]  

  • 13. [The therapeutic effect of corticosteroids on the symptoms and course of multiple sclerosis].
    Mayer K; Trübestein G; Diefenbach C
    Med Welt; 1970 Mar; 10():392-5. PubMed ID: 4314318
    [No Abstract]   [Full Text] [Related]  

  • 14. Activity of adenosine deaminase in red blood cells of patients suffering from multiple sclerosis treated with adrenocorticotropic hormone.
    Kopff M; Zakrzewska I; Klem J; Puczkowski S; Strzelczyk M; Czernicki J; Chmielewski H
    Pol J Pharmacol; 1995; 47(6):525-30. PubMed ID: 8868375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cyclophosphamide in the therapy of multiple sclerosis].
    Salvatores U; Majeron M; Mascetti A
    Riv Sper Freniatr Med Leg Alien Ment; 1972 Feb; 96(1):163-84. PubMed ID: 4337775
    [No Abstract]   [Full Text] [Related]  

  • 16. Influence of ACTH on activity of some granulocytic proteases in patients with multiple sclerosis.
    Czernicki J; Tchórzewski H; Chmielewski H
    Arch Immunol Ther Exp (Warsz); 1979; 27(3):345-9. PubMed ID: 224833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Evaluation of ACTH and corticosteroid therapy in multiple sclerosis].
    Hamel-Puskarić N; Arko K; Dupelj M; Novak Z; Barac B; Czukor M
    Neuropsihijatrija; 1969; 17(1):51-70. PubMed ID: 4191305
    [No Abstract]   [Full Text] [Related]  

  • 18. [Treatment of neurologic diseases with synthetic corticotropin (beta-1-24-corticotropin)].
    Steinbrecher W
    Med Welt; 1969 Nov; 48():2636-49. PubMed ID: 4318400
    [No Abstract]   [Full Text] [Related]  

  • 19. Serum cholesterol in health and disease.
    Civin WH
    Ann Clin Lab Sci (1971); 1972; 2(5):367-75. PubMed ID: 4563228
    [No Abstract]   [Full Text] [Related]  

  • 20. A serum lymphotoxic factor in multiple sclerosis.
    Stjernholm R; Wheelock EF; van den Noort S
    Neurology; 1970 Apr; 20(4):389. PubMed ID: 5535012
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.